Snapshot from Apr 21, 2026 at 07:00 UTC. For live data and tracking: View Live
Entities / Luke Laffin
Person

Luke Laffin

Tracked across 1 events · 11 articles · First seen Feb 11, 2026 · Last active Feb 11, 2026

Sentiment
50
Attention
6
Events
1
Relationships
1
Live sentiment trends, attention charts, and prominence tracking available on the NewsDesk Dashboard
Events (1)
6 50
Tech
Gene-Editing for High Cholesterol Breakthrough
Luke Laffin, a preventive cardiologist at the Cleveland Clinic, co-authored a promising study on the ANGPTL3 gene-editing approach funded by CRISPR Therapeutics, highlighting the potential for a one-time fix for high cholesterol.
Feb 11, 2026 · 11 articles
Relationships (1)
Cleveland Clinic cardiologist ↔ Luke Laffin Luke Laffin is a preventive cardiologist at the Cleveland Clinic.
NEWSDESK
Track Luke Laffin live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About NewsDesk

NewsDesk is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.newsdesk.dev.